Paclitaxel protein-bound particles 100 mg/20mL
Paclitaxel protein-bound particles · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · Cipla USA Inc.
Paclitaxel protein-bound particles is a injection, powder, lyophilized, for suspension containing paclitaxel protein-bound particles at 100 mg/20mL, taken intravenous. Manufactured by Cipla USA Inc..
Key Facts
- Brand Name
- Paclitaxel protein-bound particles
- Generic Name
- Paclitaxel protein-bound particles
- NDC Code (Product)
69097-398- Manufacturer
- Cipla USA Inc.
- Strength
- 100 mg/20mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA209657
- Drug Class
- Microtubule Inhibitor [EPC]
- Marketing Start
- 04/15/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Paclitaxel protein-bound particles used for?
Paclitaxel protein-bound particles contains Paclitaxel protein-bound particles. It is a injection, powder, lyophilized, for suspension taken intravenous. Consult your doctor for specific uses.
Is Paclitaxel protein-bound particles a controlled substance?
Paclitaxel protein-bound particles is not classified as a controlled substance by the DEA.
What is the generic name for Paclitaxel protein-bound particles?
The generic name for Paclitaxel protein-bound particles is Paclitaxel protein-bound particles. There are no other listed brand versions of Paclitaxel protein-bound particles.
What is the NDC code for Paclitaxel protein-bound particles 100 mg/20mL?
The NDC (National Drug Code) for Paclitaxel protein-bound particles 100 mg/20mL is 69097-398, listed by Cipla USA Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)